Cargando…
Patient‐reported outcomes from the investigational device exemption study of the Tablo hemodialysis system
INTRODUCTION: We recently completed an Investigational Device Exemption (IDE) study in which 30 patients were enrolled (13 patients previously on home hemodialysis (HHD) and 17 patients new to HHD) and treated with the Tablo Hemodialysis System (Outset Medical, Inc., San Jose, CA) for 8 weeks in‐cen...
Autores principales: | Chertow, Glenn M., Alvarez, Luis, Plumb, Troy J., Prichard, Sarah S., Aragon, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692883/ https://www.ncbi.nlm.nih.gov/pubmed/32851807 http://dx.doi.org/10.1111/hdi.12869 |
Ejemplares similares
-
Safety and efficacy of the Tablo hemodialysis system for in‐center and home hemodialysis
por: Plumb, Troy J., et al.
Publicado: (2019) -
Self‐care training using the Tablo hemodialysis system
por: Plumb, Troy J., et al.
Publicado: (2020) -
Extension of Tablo TrEatmeNt Duration (XTEND) study: successful 24 h prolonged therapy with Tablo in critical patients
por: Zaman, Tahir, et al.
Publicado: (2022) -
69 An Academic Hospital’s Inpatient Dialysis Unit’s Staff and Patient Experience With Use of Tablo Hemodialysis System
Publicado: (2021) -
24 Improved Dialysis Symptom Index with Tablo Thrice Weekly Dialysis
Publicado: (2021)